World’s Leading Nutrition Researchers Discuss Future Lines of Research on Nuts and Dried Fruit at NUTS 2025
REUS, Spain, Oct. 22, 2025 /PRNewswire/ -- Leading health researchers from around…
Subcutaneous RYBREVANT(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer
Responses were rapid and durable, and tumour shrinkage was observed in 82…
HKUST Scientists Reveal Critical Impacts of a Chinese Genetic Risk Factor in Alzheimer’s Disease
HONG KONG, Oct. 2, 2025 /PRNewswire/ -- A landmark study conducted by…
CeraVe and L’Oral Groupe Win Prestigious IFSCC Applied Research Award for Breakthrough Dandruff Study
New findings reveal critical microbial drivers, ethnic variations, and new pathways for…
Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering…
Majority of Global Employers Remain Unprepared for Pay Transparency Laws, Aon Finds
Organizations remain focused on compliance rather than embracing transparency as a strategic…
Despite Global Headwinds, Domestic Demand and Prudent Investment drive Small Business Optimism- ASSOCHAM-Dun & Bradstreet’s Small Business Confidence Index
MUMBAI, India, June 13, 2025 /PRNewswire/ -- ASSOCHAM along with Dun & Bradstreet,…
ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy
VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing…